Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha variable 8-2 (TRAV8-2) refers to the variable region of the alpha chain in the T cell receptor (TCR) complex, specifically one of many gene segments that can be recombined to provide antigen specificity to individual T cells. The TCR is a membrane-bound heterodimer typically composed of alpha and beta chains, where the alpha chain contains a variable (V) and constant (C) region. TRAV8-2 is one member of the variable gene segments (Vα) contributing to the diversity of the antigen-binding site, recognizing peptides bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells. The genetic rearrangement of V, J, and C segments during thymic development generates a highly diverse T cell repertoire essential for adaptive immunity. The engagement of a TCR containing TRAV8-2 with peptide/MHC leads to T cell activation through phosphorylation cascades and eventual immune responses or tolerance. Dysfunction or abnormal clonal expansion of specific TCRs, including those utilizing TRAV8-2, may be implicated in autoimmune disease, infection, and malignancy.
Drugs targeting the T cell receptor typically inhibit T cell activation, block antigen recognition, or deplete T cells through immune modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha variable 8-2 (TRAV8-2).